GOID	Ontology Source	GOTerm	GOLevels	GOGroups	Nr. Genes	% Associated Genes	Term PValue	Term PValue Corrected with Bonferroni step down	Group PValue	Group PValue Corrected with Bonferroni step down	Associated Genes Found	All Associated Genes	OverViewTerm
WP:22	WikiPathways_09.11.2015	IL-9 Signaling Pathway	[-1]	[Group12]	1	5.882353	0.1938846352486073	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[CDK9, GRB2, IL2RG, IL9, IL9R, JAK1, JAK3, MAP2K1, MAP2K2, MAPK1, MAPK3, PIK3R1, PIK3R2, STAT1, STAT3, STAT5A, STAT5B]	FALSE
WP:26	WikiPathways_09.11.2015	Signal Transduction of S1P Receptor	[-1]	[Group12]	1	4.0	0.2718277548262036	0.2718277548262036	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[AKT1, AKT2, AKT3, ASAH1, GNAI1, GNAI2, GNAI3, MAPK1, MAPK12, MAPK3, MAPK4, MAPK6, MAPK7, PIK3C2B, PLCB1, PLCB2, PLCB3, RACGAP1, S1PR1, S1PR2, S1PR3, S1PR5, SMPD2, SPHK1, SPHK2]	FALSE
WP:45	WikiPathways_09.11.2015	G1 to S cell cycle control	[-1]	[Group12, Group8]	5	7.352941	0.0015136108547862998	0.08476220786803279	{Group12=1.2190730591512093E-5, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group8=4.8659373939131026E-11}	[ATM, CCNE2, MCM2, MDM2, MYC]	[ATF6B, ATM, CCNA1, CCNB1, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG2, CCNH, CDC25A, CDC45, CDK1, CDK2, CDK4, CDK6, CDK7, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDKN2B, CDKN2C, CDKN2D, CREB1, CREB3, CREB3L1, CREB3L3, CREB3L4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, GADD45A, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MDM2, MNAT1, MYC, MYT1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA2, POLE, POLE2, PRIM1, PRIM2, RB1, RBL1, RPA1, RPA2, RPA3, TFDP1, TFDP2, TP53, WEE1]	FALSE
WP:49	WikiPathways_09.11.2015	IL-2 Signaling Pathway	[-1]	[Group1, Group12]	3	7.142857	0.015344914075657903	0.5831067348750003	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4}	[HRAS, MAPK1, MYC]	[AKT1, BCL2, CBL, CCND2, CISH, CRKL, FOS, FOXO3, FYN, GAB2, GRB2, HRAS, IL2, IL2RA, IL2RB, IL2RG, JAK1, JAK3, JUN, LCK, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPT, MYC, NMI, PIK3R1, PTK2B, PTPN11, RAF1, RPS6, RPS6KB1, RPS6KB2, SHC1, SOCS3, SOS1, STAT1, STAT3, STAT5A, STAT5B, SYK]	FALSE
WP:78	WikiPathways_09.11.2015	TCA Cycle	[-1]	[Group15]	1	5.882353	0.1938846352486073	1.0	{Group15=0.2718277548262036}	{Group15=0.2718277548262036}	[CS]	[ACO2, CS, DLD, DLST, FH, IDH2, IDH3A, IDH3B, IDH3G, MDH2, OGDH, SDHA, SDHB, SDHC, SDHD, SUCLG1, SUCLG2]	FALSE
WP:127	WikiPathways_09.11.2015	IL-5 Signaling Pathway	[-1]	[Group12]	4	10.0	0.001475809753437492	0.08412115594593705	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[JAK2, KRAS, MAPK1, MYC]	[AKT1, BCL2, BTK, CSF2RB, ELK1, FOS, FOXO3, GRB2, GSK3A, GSK3B, IL2, IL5RA, JAK1, JAK2, JUN, KRAS, LYN, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPT, MYC, PIK3CG, PIK3R1, PIK3R2, PTPN11, RAF1, RPS6, RPS6KA1, RPS6KB1, RPS6KB2, SHC1, SOS1, SPRED1, STAT1, STAT3, STAT5A, STAT5B, SYK]	FALSE
WP:134	WikiPathways_09.11.2015	Pentose Phosphate Pathway	[-1]	[Group0]	1	14.285714	0.08483855525537254	1.0	{Group0=0.08483855525537254}	{Group0=0.5090313315322352}	[RPE]	[G6PD, PGD, PGLS, RPE, RPIA, TALDO1, TKT]	TRUE
WP:179	WikiPathways_09.11.2015	Cell Cycle	[-1]	[Group8]	9	8.7378645	4.284566393830734E-6	3.256270459311358E-4	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ARF1, ATM, CCNA2, CCNE2, CHEK1, MCM10, MCM2, MDM2, MEN1]	[ABL1, APC, ARF1, ATM, ATR, BUB1, BUB1B, BUB3, CCNA1, CCNA2, CCNB1, CCNB2, CCNB3, CCND2, CCND3, CCNE1, CCNE2, CCNH, CDC14A, CDC14B, CDC20, CDC25A, CDC25B, CDC25C, CDC45, CDC6, CDC7, CDH1, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CHEK1, CHEK2, DBF4, E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, EP300, ESPL1, GADD45A, GSK3B, HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, KITLG, MAD1L1, MAD2L1, MAD2L2, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, MCM8, MCM9, MDM2, MEN1, MPEG1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, PKMYT1, PLK1, PRKDC, PTTG1, PTTG2, PTTG3P, RB1, RBL1, SKP2, SMAD3, SMAD4, SMC1A, TBC1D8, TFDP1, TGFB1, TP53, UBE2F, WEE1, YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ]	FALSE
WP:186	WikiPathways_09.11.2015	Homologous recombination	[-1]	[Group8]	4	30.76923	1.4883922958204929E-5	0.0011014102989071648	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, POLD1, RAD50, RAD51]	[ATM, BRCA2, MRE11A, NBN, POLD1, POLD2, POLD3, POLD4, RAD50, RAD51, RAD52, RAD54B, RPA1]	FALSE
WP:205	WikiPathways_09.11.2015	IL-7 Signaling Pathway	[-1]	[Group12]	3	12.0	0.0035758432707611474	0.16806463372577393	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[BCL2L1, MAPK1, MYC]	[AKT1, BAD, BCL2L1, CCND1, CDKN1B, FYN, GSK3B, IL2RA, IL2RG, IL7, IL7R, JAK1, JAK3, MAP2K1, MAP2K2, MAPK1, MAPK3, MYC, PIK3R1, PIK3R2, PTK2B, STAT1, STAT3, STAT5A, STAT5B]	FALSE
WP:231	WikiPathways_09.11.2015	TNF alpha Signaling Pathway	[-1]	[Group1, Group12, Group3]	7	7.6086955	1.3311585157930398E-4	0.009051877907392671	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[BCL2L1, BID, HRAS, KRAS, MAP2K4, MAPK1, RIPK1]	[AKT1, APAF1, BAD, BAX, BCL2L1, BID, BIRC2, BIRC3, BTRC, CASP3, CASP7, CASP8, CASP9, CCL2, CDC37, CFLAR, CHUK, CREBBP, CSNK2A1, CUL1, CYBA, DIABLO, FADD, FBXW11, GLUL, GRB2, HRAS, HSP90AA1, IKBKB, IKBKG, IL6, JUN, KRAS, KSR1, KSR2, MADD, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K3, MAP3K5, MAP3K7, MAP3K8, MAP4K2, MAPK1, MAPK3, MAPK8, MAPK9, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, NOX1, NOXO1, NRAS, NSMAF, OTUD7B, PLK1, PPP2CA, PRKCZ, PSMD2, PTPRCAP, PYGL, RAC1, RAF1, REL, RFFL, RFK, RIPK1, RIPK3, SELE, SKP1, SMPD2, SOS1, TAB1, TAB2, TAB3, TANK, TBK1, TNF, TNFAIP3, TNFRSF1A, TNFRSF1B, TRADD, TRAF1, TRAF2, TRAP1, TXN]	TRUE
WP:244	WikiPathways_09.11.2015	Alpha 6 Beta 4 signaling pathway	[-1]	[Group12, Group2]	3	9.090909	0.007898998939771569	0.33965695441017746	{Group12=1.2190730591512093E-5, Group2=0.025816580286709155}	{Group12=1.828609588726814E-4, Group2=0.2323492225803824}	[HRAS, MAPK1, MTOR]	[AKT1, EIF4EBP1, GAB1, GRB2, HRAS, IRS1, IRS2, ITGA6, ITGB4, LAMA1, LAMA2, LAMA3, LAMA5, LAMB1, LAMB2, LAMB3, LAMC1, LAMC2, MAPK1, MAPK14, MAPK3, MTOR, PIK3R1, PIK3R2, PRKCA, PRKCD, PTK2, PTPN11, RAC1, RHOA, SHC1, SOS1, SRC]	TRUE
WP:254	WikiPathways_09.11.2015	Apoptosis	[-1]	[Group1, Group3, Group8]	8	9.523809	8.07594332897142E-6	6.056957496728564E-4	{Group1=3.207445269990176E-5, Group3=8.052769945241409E-5, Group8=3.041210871195689E-12}	{Group1=4.4904233779862466E-4, Group3=0.001046860092881383, Group8=4.8659373939131026E-11}	[BCL2L1, BCL2L11, BID, FAS, MAP2K4, MDM2, MYC, RIPK1]	[AKT1, APAF1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L1, BCL2L11, BCL2L2, BID, BIRC2, BIRC3, BIRC5, BNIP3L, BOK, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CHUK, CRADD, CYCS, DFFA, DFFB, DIABLO, FADD, FAS, FASLG, GZMB, HELLS, HRK, IGF1, IGF1R, IGF2, IKBKB, IKBKG, IRF1, IRF2, IRF3, IRF4, IRF5, IRF6, IRF7, JUN, LTA, MAP2K4, MAP3K1, MAPK10, MCL1, MDM2, MYC, NFKB1, NFKBIA, NFKBIB, NFKBIE, PIK3R1, PMAIP1, PRF1, RELA, RIPK1, SCAF11, TNF, TNFRSF10B, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFSF10, TP53, TP63, TP73, TRADD, TRAF1, TRAF2, TRAF3, XIAP]	TRUE
WP:262	WikiPathways_09.11.2015	EBV LMP1 signaling	[-1]	[Group12]	1	5.0	0.22403046428652973	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[CCL20, CHUK, CXCL8, HSP90AA1, IFNB1, IKBKB, IRAK1, MAP3K14, MAP3K3, MAP3K7, MAPK1, MAPK8, NFKB1, NFKB2, NFKBIA, PDLIM7, RELA, TRADD, TRAF1, TRAF6]	FALSE
WP:286	WikiPathways_09.11.2015	IL-3 Signaling Pathway	[-1]	[Group12, Group3]	4	8.163265	0.003145033852008659	0.15096162489641562	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[BCL2L1, HRAS, JAK2, MAPK1]	[AKT1, BAD, BCL2, BCL2L1, CBL, CCR3, CD69, CD86, CRKL, CSF2RB, CXCL8, ENPP3, FOS, FYN, GAB2, GRB2, HCK, HRAS, IL3, IL3RA, IL5RA, INPP5D, JAK1, JAK2, JUN, LYN, MAP2K1, MAPK1, MAPK3, MAPK8, PIK3CD, PIK3R1, PIK3R2, PRKACA, PTPN11, PTPN6, RAF1, RAPGEF1, SHC1, SOS1, SRC, STAT3, STAT5A, STAT5B, SYK, TGFB1, VAV1, YWHAB, YWHAQ]	FALSE
WP:299	WikiPathways_09.11.2015	Nuclear Receptors in Lipid Metabolism and Toxicity	[-1]	[Group10]	2	5.5555553	0.07463077028632545	1.0	{Group10=0.0833982410159817}	{Group10=0.5837876871118719}	[CYP2C9, NR1I2]	[ABCA1, ABCB1, ABCB11, ABCB4, ABCC2, ABCC3, ABCD2, ABCD3, ABCG1, ABCG5, CYP1A2, CYP24A1, CYP26A1, CYP27B1, CYP2B6, CYP2C9, CYP2E1, CYP3A4, CYP4A11, CYP4A22, CYP4B1, CYP7A1, CYP8B1, MIR33A, MIR33B, NR1H3, NR1H4, NR1I2, NR1I3, PPARA, PPARD, PPARG, RARA, RARB, RARG, VDR]	FALSE
WP:304	WikiPathways_09.11.2015	Kit receptor signaling pathway	[-1]	[Group12]	3	5.084746	0.03740848443618153	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[HRAS, JAK2, MAPK1]	[AKT1, BAD, BCL2, BTK, CBL, CRK, CRKL, DOK1, EP300, FOS, FOXO3, FYN, GAB2, GRB10, GRB2, GRB7, HRAS, INPP5D, JAK2, JUNB, KIT, KITLG, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPT, MATK, MITF, PIK3R1, PIK3R2, PLCG1, PRKCA, PRKCB, PTPN11, PTPN6, RAF1, RPS6, RPS6KA1, RPS6KA3, RPS6KB1, SH2B2, SHC1, SNAI1, SNAI2, SOCS1, SOCS6, SOS1, SRC, STAT1, STAT3, STAT5A, STAT5B, TBX2, TEC, VAV1]	FALSE
WP:313	WikiPathways_09.11.2015	Signaling of Hepatocyte Growth Factor Receptor	[-1]	[Group12]	3	8.823529	0.00858674812201319	0.36064342112455394	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[HRAS, MAPK1, MET]	[CRK, CRKL, DOCK1, ELK1, FOS, GAB1, GRB2, HGF, HRAS, ITGA1, ITGB1, JUN, MAP2K1, MAP2K2, MAP4K1, MAPK1, MAPK3, MAPK8, MET, PAK1, PIK3CA, PTEN, PTK2, PTK2B, PTPN11, PXN, RAF1, RAP1A, RAP1B, RAPGEF1, RASA1, SOS1, SRC, STAT3]	FALSE
WP:314	WikiPathways_09.11.2015	FAS pathway and Stress induction of HSP regulation	[-1]	[Group12]	2	4.7619047	0.0972882751797125	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[FAS, MAP2K4]	[ACTA1, ACTB, ACTG1, APAF1, ARHGDIB, BCL2, CASP10, CASP3, CASP6, CASP7, CASP8, CASP9, CFLAR, CYCS, DAXX, DFFA, DFFB, FADD, FAF1, FAS, FASLG, HSPB1, IL1A, JUN, LMNA, LMNB1, LMNB2, MAP2K4, MAP3K1, MAP3K7, MAPK8, MAPKAPK2, MAPKAPK3, NFX1, PAK1, PAK2, PARP1, PRKDC, RB1, RIPK2, SPTAN1, TNF]	FALSE
WP:322	WikiPathways_09.11.2015	Osteoblast Signaling	[-1]	[Group11, Group12]	2	14.285714	0.012849278131442491	0.5011218471262572	{Group11=0.0034640410527188486, Group12=1.2190730591512093E-5}	{Group11=0.038104451579907335, Group12=1.828609588726814E-4}	[PDGFRA, PDGFRB]	[BGLAP, COL1A1, FGF23, IBSP, ITGAV, ITGB3, PDGFB, PDGFRA, PDGFRB, PTH, PTH1R, SLC17A2, TNFRSF11B, TNFSF11]	FALSE
WP:363	WikiPathways_09.11.2015	Wnt Signaling Pathway Netpath	[-1]	[Group12]	4	7.6923075	0.0039074739473421854	0.17974380157774053	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1, MTOR, MYC, PI4K2A]	[AKT1, APC, ARRB2, AXIN1, AXIN2, BCL9, CCND1, CDK6, CSNK1A1, CSNK1D, CSNK1E, CSNK1G1, CTBP1, CTNNB1, DVL1, DVL2, DVL3, FRAT1, GCKR, GJA1, GSK3A, GSK3B, LEF1, LOC400927-CSNK1E, LRP5, LRP6, MAP3K7, MAPK1, MAPK8, MAPK9, MTOR, MYC, NFATC2, NLK, PI4K2A, PIP5K1B, PPARG, PRKCA, PRKCB, PRKCG, RAC1, RHOA, ROR1, ROR2, RYK, SOX1, TCF3, TCF4, TCF7L2, TEK, TSC1, TSC2]	FALSE
WP:364	WikiPathways_09.11.2015	IL-6 signaling pathway	[-1]	[Group12, Group3]	4	9.302325	0.0019376531074177083	0.10075796158572083	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[BCL2L1, JAK2, MAP2K4, MAPK1]	[AGT, AKT1, BAD, BCL2L1, CREBBP, CRP, GAB1, GRB2, GSK3B, HCK, HDAC1, IL6, IL6R, IL6ST, IRF1, JAK1, JAK2, JUNB, MAP2K1, MAP2K2, MAP2K4, MAP3K7, MAPK1, MAPK3, NCOA1, NLK, NR2F6, PIK3R1, PIK3R2, PRDM1, PRKCD, PTPN11, RAC1, RPS6KB1, SHC1, SOCS3, SOS1, STAT1, STAT3, TIMP1, TYK2, VAV1, VIP]	FALSE
WP:382	WikiPathways_09.11.2015	MAPK Signaling Pathway	[-1]	[Group12, Group6]	7	4.1666665	0.0047616432229747475	0.21427394503386363	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557}	[EGFR, FAS, KRAS, MAP2K4, MAPK1, MYC, PDGFRB]	[ACVR1B, ACVR1C, AKT1, AKT2, AKT3, ARRB1, ARRB2, ATF2, ATF4, BDNF, BRAF, CASP1, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CD14, CDC25B, CDC42, CRK, CRKL, DAXX, DDIT3, DUSP1, DUSP10, DUSP4, DUSP5, DUSP6, DUSP7, ECSIT, EGF, EGFR, ELK1, FAS, FASLG, FGF4, FGFR1, FLNA, FOS, GADD45A, GCK, GNA12, GRB2, HSPA1A, HSPA5, HSPA8, HSPB1, HSPB2, IKBKB, IKBKG, IL1A, IL1B, IL1R1, IL1R2, JUN, JUND, KRAS, LAMTOR3, LRRK2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K11, MAP3K12, MAP3K13, MAP3K14, MAP3K2, MAP3K4, MAP3K5, MAP3K6, MAP3K7, MAP3K8, MAP4K1, MAP4K3, MAP4K4, MAPK1, MAPK10, MAPK12, MAPK13, MAPK14, MAPK3, MAPK4, MAPK6, MAPK7, MAPK8, MAPK8IP3, MAPK9, MAPKAPK2, MAPKAPK5, MAPT, MAX, MEF2C, MINK1, MKNK1, MOS, MRAS, MYC, NF1, NFATC1, NFKB1, NGF, NLK, NR4A1, NRAS, NTF4, NTRK1, PAK1, PAK2, PDGFB, PDGFRB, PLA2G10, PLA2G5, PPM1A, PPM1B, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, PPP5C, PRKACA, PRKCB, PRKCD, PRKCG, PRKCH, PRKCZ, PTPN5, PTPN7, PTPRR, RAC1, RAC2, RAF1, RAP1A, RAP1B, RASA1, RASA2, RASGRF2, RASGRP1, RASGRP4, RPS6KA3, RPS6KA5, SH2D1A, SOS2, SRF, STK3, STMN1, TAB1, TAB2, TAOK1, TAOK2, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM37, TNF, TP53, TRAF2, TRAF6, ZAK]	FALSE
WP:384	WikiPathways_09.11.2015	Apoptosis Modulation by HSP70	[-1]	[Group1]	3	15.789474	0.0015895260452320039	0.08583440644252821	{Group1=3.207445269990176E-5}	{Group1=4.4904233779862466E-4}	[BID, FAS, RIPK1]	[AIFM1, APAF1, BID, CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CYCS, FADD, FAS, FASLG, HSPA1A, MAP3K1, MAPK10, NFKB1, RIPK1, TNFRSF1A]	FALSE
WP:400	WikiPathways_09.11.2015	p38 MAPK Signaling Pathway	[-1]	[Group1, Group12, Group3]	4	11.764706	7.922573905547077E-4	0.048327700823837166	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, MAP2K4, MYC, RIPK1]	[ATF2, CDC42, CREB1, DAXX, DDIT3, ELK1, GRB2, HMGN1, HRAS, HSPB1, MAP2K4, MAP2K6, MAP3K1, MAP3K5, MAP3K7, MAP3K9, MAPK14, MAPKAPK2, MAPKAPK5, MAX, MEF2D, MKNK1, MYC, PLA2G4A, RAC1, RASGRF1, RIPK1, RPS6KA5, SHC1, STAT1, TGFB2, TGFBR1, TRADD, TRAF2]	FALSE
WP:404	WikiPathways_09.11.2015	Nucleotide Metabolism	[-1]	[Group14]	2	10.526316	0.023193352207310385	0.8581540316704842	{Group14=0.008199735962594748}	{Group14=0.08199735962594748}	[POLD1, RRM1]	[ADSL, ADSS, DHFR, HPRT1, IMPDH1, MTHFD2, NME2, OAZ1, POLA1, POLB, POLD1, POLG, PRPS1, PRPS2, RRM1, RRM2, RRM2B, SAT1, SRM]	FALSE
WP:422	WikiPathways_09.11.2015	MAPK Cascade	[-1]	[Group1, Group12, Group3]	4	13.793103	4.252573850237582E-4	0.027216472641520526	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, KRAS, MAP2K4, MAPK1]	[ARAF, BRAF, ELK1, HRAS, JUN, KRAS, MAP2, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K12, MAP3K2, MAP3K3, MAPK1, MAPK10, MAPK12, MAPK14, MAPK3, MBP, NRAS, PLCB3, RAF1, RASA3, RRAS, SIPA1]	FALSE
WP:438	WikiPathways_09.11.2015	Non-homologous end joining	[-1]	[Group8]	1	14.285714	0.08483855525537254	1.0	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[RAD50]	[MRE11A, NHEJ1, PRKDC, RAD50, XRCC4, XRCC5, XRCC6]	FALSE
WP:465	WikiPathways_09.11.2015	Tryptophan metabolism	[-1]	[Group13]	2	4.347826	0.11334062371226608	1.0	{Group13=0.11334062371226608}	{Group13=0.4533624948490643}	[MDM2, UBE3A]	[AADAT, AANAT, ACAT1, ACMSD, AFMID, ALDH1A1, ALDH1A2, ALDH2, ALDH3A2, ALDH9A1, AOC1, AOX1, ASMT, CAT, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C18, CYP2E1, CYP2F1, CYP2J2, CYP3A4, CYP4F12, CYP7B1, DDC, DHCR24, ECHS1, GCDH, HAAO, HADH, HSD17B10, IDO1, INMT, KYNU, MAOB, MDM2, OGDH, PRMT1, RNF25, TDO2, TPH1, UBE3A, UBR5, WARS]	TRUE
WP:466	WikiPathways_09.11.2015	DNA Replication	[-1]	[Group14]	3	7.142857	0.015344914075657903	0.5831067348750003	{Group14=0.008199735962594748}	{Group14=0.08199735962594748}	[MCM10, MCM2, POLD1]	[CDC45, CDC6, CDC7, CDK2, CDT1, DBF4, GMNN, MCM10, MCM2, MCM3, MCM4, MCM5, MCM6, MCM7, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, PCNA, POLA1, POLA2, POLD1, POLD2, POLD3, POLD4, POLE, POLE2, PRIM1, PRIM2, RFC1, RFC2, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RPA4, UBA52, UBC]	TRUE
WP:531	WikiPathways_09.11.2015	Mismatch repair	[-1]	[Group14]	1	11.111111	0.10774954813916021	1.0	{Group14=0.008199735962594748}	{Group14=0.08199735962594748}	[POLD1]	[EXO1, LIG1, MLH1, MSH2, MSH6, PCNA, POLD1, RFC1, RPA1]	FALSE
WP:581	WikiPathways_09.11.2015	EPO Receptor Signaling	[-1]	[Group12]	2	7.6923075	0.04168005039534468	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[JAK2, MAPK1]	[AKT1, CISH, EPO, EPOR, GRB2, IRS1, IRS2, JAK2, MAP2K1, MAP2K2, MAPK1, MAPK3, PDK1, PIK3CG, PTPRC, PTPRU, RAF1, RASA1, SHC1, SOCS1, SOS1, SRC, STAT1, STAT3, STAT5A, STAT5B]	FALSE
WP:615	WikiPathways_09.11.2015	Senescence and Autophagy in Cancer	[-1]	[Group12]	5	4.7619047	0.009838723141741678	0.39354892566966715	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[COL3A1, HRAS, MAPK1, MDM2, MTOR]	[AKT1S1, AMBRA1, ATG10, ATG12, ATG13, ATG14, ATG16L1, ATG3, ATG5, ATG7, BCL2, BECN1, BMI1, BMP2, BRAF, CCL3, CD44, CDC25B, CDKN1A, CDKN1B, CDKN2A, CEBPB, COL10A1, COL1A1, COL3A1, CREG1, CXCL1, CXCL14, CXCL8, E2F1, FKBP8, FN1, GABARAP, GABARAPL1, GABARAPL2, GSK3B, GSN, HMGA1, HRAS, IFI16, IFNB1, IFNG, IGF1, IGF1R, IGFBP3, IGFBP5, IGFBP7, IL1A, IL1B, IL24, IL3, IL6, IL6R, IL6ST, ING1, ING2, INHBA, INS, IRF1, IRF5, IRF7, JUN, KMT2A, LAMP1, LAMP2, MAP1LC3A, MAP1LC3B, MAP1LC3C, MAP2K1, MAP2K3, MAPK1, MAPK14, MDM2, MLST8, MMP14, MTOR, PCNA, PIK3C3, PLAT, PLAU, PTEN, RAF1, RB1, RB1CC1, RNASEL, RSL1D1, SERPINB2, SERPINE1, SH3GLB1, SLC39A1, SLC39A2, SLC39A3, SLC39A4, SMAD3, SMAD4, SPARC, SQSTM1, SRC, TGFB1, THBS1, TNFSF15, TP53, ULK1, UVRAG, VTN]	FALSE
WP:666	WikiPathways_09.11.2015	Hypothetical Network for Drug Addiction	[-1]	[Group12]	2	6.25	0.06064657065399543	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[KRIT1, MAPK1]	[ACTA1, ADCY1, ADCY8, CAMK2B, CAMK4, CREB1, DRD1, DRD2, DRD4, GJB7, GRIA1, GRIA2, GRIA3, GRIA4, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRM1, GRM5, KRIT1, MAP2K1, MAP2K2, MAPK1, MAPK3, NISCH, PPA1, PRKACA, PRKCE, TERF2IP, ZHX2]	FALSE
WP:673	WikiPathways_09.11.2015	ErbB Signaling Pathway	[-1]	[Group12, Group8]	8	14.545455	2.997797476638213E-7	2.3682600065441883E-5	{Group12=1.2190730591512093E-5, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group8=4.8659373939131026E-11}	[BCL2L11, EGFR, HRAS, KRAS, MAPK1, MDM2, MTOR, MYC]	[ABL1, AKT3, ARAF, AREG, BAD, BCL2L11, BTC, CAMK2A, CBLC, CCND1, CDKN1A, CDKN1B, CRK, EGF, EGFR, EIF4EBP1, ELK1, ERBB2, ERBB3, ERBB4, EREG, FOXO1, GAB1, GRB2, GSK3B, HBEGF, HRAS, JUN, KRAS, MAP2K1, MAP2K7, MAPK1, MAPK8, MDM2, MIR21, MTOR, MYC, NCK1, NRG1, NRG2, NRG3, NRG4, PAK4, PDK1, PIK3R5, PLCG1, PRKCA, PTK2, RPS6KB1, SHC2, SOS1, SRC, STAT5A, TGFA, TP53]	FALSE
WP:678	WikiPathways_09.11.2015	Arachidonate Epoxygenase / Epoxide Hydrolase	[-1]	[Group10]	1	14.285714	0.08483855525537254	1.0	{Group10=0.0833982410159817}	{Group10=0.5837876871118719}	[CYP2C9]	[COX5A, COX8A, CYP2C8, CYP2C9, CYP2J2, EPHX2, GSTP1]	FALSE
WP:691	WikiPathways_09.11.2015	Tamoxifen metabolism	[-1]	[Group10]	1	4.7619047	0.23383049362054006	0.9353219744821603	{Group10=0.0833982410159817}	{Group10=0.5837876871118719}	[CYP2C9]	[CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, FMO1, FMO3, SULT1A1, SULT1E1, SULT2A1, UGT1A10, UGT1A4, UGT1A8, UGT2B15, UGT2B7]	TRUE
WP:707	WikiPathways_09.11.2015	DNA Damage Response	[-1]	[Group8]	9	13.235294	1.1845124759648393E-7	9.594551055315197E-6	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, BID, CCNE2, CHEK1, FAS, MDM2, MYC, RAD50, RAD51]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MDM2, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	FALSE
WP:710	WikiPathways_09.11.2015	DNA Damage Response (only ATM dependent)	[-1]	[Group12, Group8]	7	6.3063064	4.282956841864031E-4	0.026982628103743394	{Group12=1.2190730591512093E-5, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group8=4.8659373939131026E-11}	[ATM, BCL2L11, HRAS, KRAS, MAPK1, MDM2, MYC]	[ABL1, AKT1, AKT2, AKT3, APC, ATM, AXIN1, BAD, BAK1, BAX, BBC3, BCL2, BCL2L11, BCL6, BIK, CAT, CCND1, CCND2, CCND3, CCNG2, CDC42, CDKN1A, CDKN1B, CDKN2A, CTNNB1, DVL1, DVL2, DVL3, ERBB2, FASLG, FOSL1, FOXO3, FRAT1, G6PC, GRB2, GSK3B, HMGB1, HRAS, INSR, IRS1, JUN, KRAS, LDLR, LEF1, LOC100129518, LOC101929777, MAP3K1, MAP3K4, MAP3K7, MAPK1, MAPK10, MAPK8, MAPK9, MDM2, MLKL, MYC, NFKB1, NFKB2, NRAS, PCK2, PDK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PIK3R4, PLAU, PMAIP1, PPP2R5C, PPP2R5E, PTEN, RAC1, RAC2, RAC3, RBL2, RHOA, SCP2, SHC1, SMAD3, SMAD4, SOD2, SOS1, SOS2, TCF7, TCF7L1, TCF7L2, TGFB1, TP53, TP73, WNT1, WNT10A, WNT10B, WNT11, WNT16, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B]	FALSE
WP:712	WikiPathways_09.11.2015	Estrogen signaling pathway	[-1]	[Group12]	1	4.347826	0.2530667461851861	0.7592002385555583	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[AKT1, BCL2, BRAF, CHUK, CREB1, ELK1, ESR1, FOS, GNAS, GNB1, GNGT1, GPER1, IKBKB, IKBKG, JUN, MAP2K1, MAPK1, MAPK14, MAPK9, NFKB1, PIK3CA, PRKACA, SP1]	FALSE
WP:732	WikiPathways_09.11.2015	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	[-1]	[Group12, Group3]	3	15.0	0.0018533690888267085	0.09822856170781555	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, KRAS, MAPK1]	[ELK1, ELK4, GATA4, GNAQ, HRAS, HTR2A, HTR2B, HTR2C, ITPR1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NRAS, RAF1, RASGRF1, RASGRP1, SRF]	FALSE
WP:733	WikiPathways_09.11.2015	Serotonin Receptor 2 and STAT3 Signaling	[-1]	[Group12]	1	25.0	0.04938306486083811	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[JAK2]	[GNAQ, HTR2A, JAK2, STAT3]	FALSE
WP:734	WikiPathways_09.11.2015	Serotonin Receptor 4/6/7 and NR3C Signaling	[-1]	[Group12]	1	5.263158	0.21410716414330672	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[ATF1, BRAF, CREB1, EGR1, ELK1, ELK4, GNAS, HTR4, HTR6, HTR7, MAP2K1, MAP2K2, MAPK1, MAPK3, MAPKAPK2, NR3C1, RAP1A, RPS6KA5, SRF]	FALSE
WP:1403	WikiPathways_09.11.2015	AMPK Signaling	[-1]	[Group2]	3	4.347826	0.055240856760764644	1.0	{Group2=0.025816580286709155}	{Group2=0.2323492225803824}	[CCNA2, MTOR, STRADA]	[ACACA, ACACB, ADIPOQ, ADIPOR1, ADIPOR2, ADRA1A, ADRA1B, AKT1, AKT2, CAB39, CAMKK1, CAMKK2, CCNA1, CCNA2, CCNB1, CDKN1A, CPT1A, CPT1B, CPT1C, CRTC2, EEF2, EEF2K, EIF4EBP1, ELAVL1, FASN, GYS1, GYS2, HMGCR, HNF4A, INS-IGF2, INSR, LEP, LEPR, LIPE, LOC101930123, MEF2BNB-MEF2B, MTOR, PFKFB3, PIK3C3, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PLCB1, PPARGC1B, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKACB, PRKACG, PRKAG1, PRKAG2, PRKAG3, RPS6KB1, RPS6KB2, RPTOR, SLC2A4, SLC2A4RG, SREBF1, STK11, STRADA, STRADB, TP53, TSC1, TSC2]	FALSE
WP:1434	WikiPathways_09.11.2015	Osteopontin Signaling	[-1]	[Group12]	1	7.6923075	0.1518919997012318	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[CHUK, IKBKB, ITGAV, ITGB3, MAP2K1, MAP3K14, MAPK1, MAPK3, MMP9, NFKB1, PLAU, RELA, SPP1]	FALSE
WP:1528	WikiPathways_09.11.2015	Physiological and Pathological Hypertrophy  of the Heart	[-1]	[Group12]	1	4.1666665	0.2625059275558935	0.525011855111787	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[AGT, CALM1, CAMK2D, CTF1, EDN1, FOS, GATA4, IL6ST, JUN, LIFR, MAP2K3, MAPK1, MAPK11, MAPK14, MAPK8, MYEF2, NFATC4, PPP3CA, PPP3CB, PRKCB, PRKCE, RAC1, RHOA, STAT3]	FALSE
WP:1530	WikiPathways_09.11.2015	miRNA Regulation of DNA Damage Response	[-1]	[Group8]	9	10.4651165	9.270934793275435E-7	7.138619790822084E-5	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, BID, CCNE2, CHEK1, FAS, MDM2, MYC, RAD50, RAD51]	[ABL1, APAF1, ATM, ATR, ATRIP, BAX, BBC3, BID, BRCA1, CASP3, CASP8, CASP9, CCNB1, CCNB2, CCNB3, CCND1, CCND2, CCND3, CCNE1, CCNE2, CCNG1, CDC20B, CDC25A, CDC25C, CDK1, CDK2, CDK4, CDK5, CDK6, CDKN1A, CDKN1B, CHEK1, CHEK2, CREB1, CYCS, DDB2, E2F1, FANCD2, FAS, GADD45A, GADD45B, GADD45G, H2AFX, HUS1B, MCM7, MDM2, MIR106B, MIR16-1, MIR17HG, MIR181A1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR3074, MIR330, MIR373, MIR449A, MIR449B, MRE11A, MYC, NBN, PIDD1, PMAIP1, PML, PRKDC, RAD1, RAD17, RAD50, RAD51, RAD52, RAD9A, RB1, RFC1, RPA2, RRM2B, SESN1, SFN, SMC1A, TLK1, TLK2, TNFRSF10B, TP53, TP53AIP1]	FALSE
WP:1539	WikiPathways_09.11.2015	Angiogenesis	[-1]	[Group11, Group12]	2	8.333333	0.03596557462625592	1.0	{Group11=0.0034640410527188486, Group12=1.2190730591512093E-5}	{Group11=0.038104451579907335, Group12=1.828609588726814E-4}	[MAPK1, PDGFRA]	[AKT1, ANGPT1, ARNT, CREBBP, FGF2, FGFR2, FLT1, HIF1A, KDR, MAPK1, MAPK14, MMP9, NOS3, PDGFB, PDGFRA, PIK3CA, PLCG1, PTK2, SMAD1, SRC, TEK, TIMP2, TIMP3, VEGFA]	FALSE
WP:1545	WikiPathways_09.11.2015	miRNAs involved in DNA damage response	[-1]	[Group12, Group6, Group8]	2	4.6511626	0.10123646135079084	1.0	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557, Group8=4.8659373939131026E-11}	[ATM, MYC]	[ABL1, ATM, CCND1, CCND3, CCNE1, CDC25A, CDK6, CDKN1A, CDKN1B, CREB1, E2F1, H2AFX, MIR100, MIR106B, MIR143, MIR15B, MIR16-1, MIR181A1, MIR181B1, MIR203A, MIR21, MIR210, MIR221, MIR222, MIR223, MIR23A, MIR23B, MIR25, MIR27A, MIR3074, MIR330, MIR371A, MIR372, MIR373, MIR449A, MIR449B, MIR449C, MIR503, MIR93, MIRLET7B, MYC, RAD52, TP53]	FALSE
WP:1584	WikiPathways_09.11.2015	Type II diabetes mellitus	[-1]	[Group12, Group2]	2	9.090909	0.030586936430291728	1.0	{Group12=1.2190730591512093E-5, Group2=0.025816580286709155}	{Group12=1.828609588726814E-4, Group2=0.2323492225803824}	[MAPK1, MTOR]	[ADIPOQ, CACNA1A, GK, IKBKB, INS-IGF2, INSR, IRS1, KCNJ11, MAFA, MAPK1, MAPK8, MTOR, PDX1, PHKA2, PIK3R5, PRKCD, PRKCZ, SLC2A2, SLC2A4, SOCS4, SURF1, TNF]	FALSE
WP:1742	WikiPathways_09.11.2015	TP53 Network	[-1]	[Group1, Group12, Group8]	4	21.052631	7.624734975294685E-5	0.00533731448270628	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5, Group8=3.041210871195689E-12}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4, Group8=4.8659373939131026E-11}	[ATM, BID, MDM2, MYC]	[ABL1, ATM, BAX, BBC3, BCL2, BID, BOK, CDKN1A, CDKN2A, GADD45A, MDM2, MYC, OTX2, PMAIP1, SUMO1, TNFSF10, TP53, TP63, TP73]	FALSE
WP:1772	WikiPathways_09.11.2015	Apoptosis Modulation and Signaling	[-1]	[Group1, Group3]	5	5.5555553	0.005168197326974008	0.22740068238685635	{Group1=3.207445269990176E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group3=0.001046860092881383}	[BCL2L1, BCL2L11, BID, FAS, RIPK1]	[AIFM1, AIFM2, APAF1, BAD, BAG3, BAK1, BAX, BBC3, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BID, BIK, BIRC2, BIRC3, BIRC5, BIRC6, BIRC7, BLK, BMF, BOK, CAPNS1, CASP1, CASP10, CASP2, CASP3, CASP4, CASP6, CASP7, CASP8, CASP9, CDKN2A, CFLAR, CRADD, CYCS, DAXX, DFFA, DFFB, DIABLO, ENDOG, FADD, FAS, FASLG, FOS, HN1, HRK, HSPA1A, HTRA2, IKBKB, IL1R1, IL1R2, IRAK1, JUN, MADD, MAP3K14, MAP3K5, MAPK3, MAPK8, MCL1, MYD88, NAIP, NFKB1, NFKBIA, PEA15, PIDD1, PMAIP1, PRKD1, PTPN13, PTRH2, RIPK1, SEPT4, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11B, TNFRSF1A, TNFRSF1B, TNFRSF25, TNFRSF6B, TNFSF10, TOLLIP, TP53, TRADD, TRAF3, TRAF6, XIAP]	FALSE
WP:1971	WikiPathways_09.11.2015	Integrated Cancer pathway	[-1]	[Group8]	6	13.043478	1.952173163105951E-5	0.0014250864090673441	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, BLM, CHEK1, MDM2, MYC, RAD50]	[AKT1, ATF1, ATM, ATR, BACH1, BAD, BARD1, BAX, BBC3, BCL2, BLM, BRCA1, CASP3, CASP8, CASP9, CDC25A, CDC25B, CDK1, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, E2F1, GRIK1-AS2, JAK1, MAP3K5, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MYC, NOXA1, PLK1, POU2F1, PTEN, RAD50, RB1, SMAD2, SMAD3, STAT1, TP53]	FALSE
WP:1984	WikiPathways_09.11.2015	Integrated Breast Cancer Pathway	[-1]	[Group12, Group8]	12	7.894737	2.6932324649821054E-7	2.1545859719856843E-5	{Group12=1.2190730591512093E-5, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group8=4.8659373939131026E-11}	[ATM, BID, BLM, CHEK1, EGFR, KRAS, MAPK1, MDM2, MTOR, MYC, RAD50, RAD51]	[ABL1, AHR, AKT1, ALKBH1, ANXA1, APOBEC3G, AR, ARAF, ATF1, ATM, ATR, AURKA, BACH1, BAD, BAK1, BARD1, BAX, BCL2, BID, BLM, BMPR1A, BMPR2, BRAF, BRCA1, BRCA2, CASP3, CASP8, CASP9, CCNB1IP1, CCND1, CDC25A, CDC25B, CDC42, CDH1, CDK2, CDK4, CDK7, CERK, CHEK1, CHEK2, CHUK, CREB1, CSNK1D, CTNNB1, CYP19A1, DAG1, DCAKD, DHTKD1, E2F1, EDAR, EGFR, EP300, ERAL1, ESR1, FADD, FAU, FER, FILIP1, FOSL1, FOXO1, GADD45A, GDI1, GRIK1-AS2, GRN, GSK3A, HDAC1, HIPK2, HMGCR, IMPA1, IRS1, ITPKC, JAK1, JAKMIP1, JUN, KRAS, LGALS13, MAP3K13, MAP3K7CL, MAPK1, MAX, MDM2, MIR21, MMP1, MRE11A, MSH2, MSH6, MTOR, MYC, MYCBP2, MYT1, NAB1, NCOA3, NF1, NFKB1, NOXA1, NUP85, ODC1, PAK1, PHB, PIAS1, PIGR, PIK3R2, PKIA, PLK1, PLK3, PML, PPP4R3A, PTEN, RAC1, RAD50, RAD51, RAD54L, RALA, RALGAPA1, RAP1A, RASGEF1A, RASGRP3, RB1, RHEB, RHO, RPP38, RRAS, SIRT1, SMAD1, SMAD2, SMAD4, SMAD6, SMAD7, SMARCA4, SP1, STAT1, STK11, TAB1, TFPI, TGFBR1, TGFBR2, TP53, TPR, TRADD, TSC1, TSC2, UBE2F, USP15, USP16, USP21, USP38, VEGFA, WEE1, XRCC3, ZMIZ1, ZMYND8, ZNF655]	FALSE
WP:2011	WikiPathways_09.11.2015	SREBF and miR33 in cholesterol and lipid homeostasis	[-1]	[Group12, Group2]	1	5.5555553	0.20405906877990704	1.0	{Group12=1.2190730591512093E-5, Group2=0.025816580286709155}	{Group12=1.828609588726814E-4, Group2=0.2323492225803824}	[MTOR]	[ABCA1, FASN, HMGCR, HMGCS1, LDLR, MED15, MIR33A, MIR33B, MTOR, NR1H3, PPARA, PPARGC1A, PRKAA1, SCD, SIRT1, SIRT6, SREBF1, SREBF2]	FALSE
WP:2032	WikiPathways_09.11.2015	TSH signaling pathway	[-1]	[Group12]	5	7.5757575	0.0013228320504721056	0.07804709097785423	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[HRAS, JAK2, MAPK1, MTOR, MYC]	[ADCY2, ADCY3, AKT1, APEX1, BRAF, CCND3, CCNE1, CDK2, CDK4, CDKN1B, CGA, CREB1, E2F1, EGR1, FOS, GNA12, GNA13, GNAI1, GNAI2, GNAI3, GNAO1, GNAQ, GNAS, GNB1, GNG2, HRAS, IGF1R, JAK1, JAK2, JUN, KCNIP3, MAP2K1, MAP2K3, MAP2K6, MAPK1, MAPK14, MAPK3, MTOR, MYC, MYL12B, PAX8, PDE4D, PDPK1, PIK3CA, PIK3R1, PIK3R2, PLCB1, PLD1, RAF1, RALGDS, RAP1A, RAP1B, RAP1GAP, RB1, RBL2, RPS6, RPS6KA1, RPS6KB1, SCRIB, SRC, STAT1, STAT3, TSHB, TSHR, TTF1, TTF2]	FALSE
WP:2034	WikiPathways_09.11.2015	Leptin signaling pathway	[-1]	[Group12, Group3]	5	6.6666665	0.0023432754347737865	0.11716377173868933	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[BCL2L1, HRAS, JAK2, MAPK1, MTOR]	[ACACA, ACACB, AKT1, BAD, BAX, BCL2L1, CCND1, CDC42, CFL2, CHUK, CISH, CREB1, EIF4E, EIF4EBP1, ELK1, ERBB2, ESR1, FOXO1, FYN, GRB2, GSK3A, GSK3B, HRAS, IKBKB, IKBKG, IL1B, IL1RN, IRS1, JAK1, JAK2, KHDRBS1, KPNA4, LEP, LEPR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MTOR, NCOA1, NFKB1, NOS3, PDE3B, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKAA1, PRKAA2, PTK2, PTPN1, PTPN11, RAC1, RAF1, REL, RELA, RHOA, ROCK1, ROCK2, RPS6, RPS6KA1, RPS6KB1, SH2B1, SHC1, SOCS2, SOCS3, SOCS7, SOS1, SP1, SRC, STAT1, STAT3, STAT5B]	FALSE
WP:2035	WikiPathways_09.11.2015	FSH signaling pathway	[-1]	[Group12, Group2]	2	7.4074073	0.04465708537848835	1.0	{Group12=1.2190730591512093E-5, Group2=0.025816580286709155}	{Group12=1.828609588726814E-4, Group2=0.2323492225803824}	[MAPK1, MTOR]	[AKT1, APPL1, AREG, BDNF, CGA, CREB1, CYP19A1, EIF4EBP1, FOXO1, FSHB, FSHR, GRK6, HIST3H3, MAPK1, MAPK14, MAPK3, MTOR, PRKACA, PRKCA, RAF1, RHEB, RPS6, RPS6KB1, RPS6KB2, SGK1, SRC, TSC2]	FALSE
WP:2036	WikiPathways_09.11.2015	TWEAK Signaling Pathway	[-1]	[Group12, Group3]	2	4.7619047	0.0972882751797125	1.0	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[MAPK1, RIPK1]	[AKT1, AKT2, BIRC2, BIRC3, CASP3, CASP7, CASP8, CCL2, CCL5, CHUK, CTNNB1, FADD, GSK3B, HDAC1, IKBKB, IL6, JUN, MAP3K14, MAP3K7, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP9, NFKB1, NFKB2, NFKBIA, NFKBIB, RAC1, RAF1, RELA, RELB, RIPK1, TNF, TNFRSF12A, TNFSF12, TRAF1, TRAF2, TRAF3, TRAF5, TRIM63]	FALSE
WP:2112	WikiPathways_09.11.2015	IL17 signaling pathway	[-1]	[Group12]	2	6.451613	0.05730897608927773	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[JAK2, MAPK1]	[AKT1, CEBPB, CEBPD, GSK3B, IKBKB, IKBKG, IL17A, IL17B, IL17C, IL17D, IL17F, IL17RA, IL17RB, IL17RC, IL17RD, IL17RE, IL25, JAK1, JAK2, MAP3K14, MAP3K7, MAPK1, MAPK3, NFKB1, NFKBIB, RELA, SP1, STAT3, TRAF3, TRAF3IP2, TRAF6]	FALSE
WP:2203	WikiPathways_09.11.2015	TSLP Signaling Pathway	[-1]	[Group12]	5	10.638298	2.7258033046412E-4	0.01799030181063192	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[JAK2, MAPK1, MTOR, MYC, PI4K2A]	[AKT1, BTK, CCL11, CISH, CRLF2, CXCL8, EIF4EBP1, FES, FYN, GAB2, HCK, IL2RA, IL6, IL7R, JAK1, JAK2, LCK, LYN, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MTOR, MYC, NFKB1, NFKB2, NFKBIA, PI4K2A, PIK3CA, PTPN11, RELA, RELB, RPS6, SRC, STAT1, STAT3, STAT4, STAT5A, STAT5B, STAT6, TEC, TNFSF4, TSLP, YES1]	FALSE
WP:2249	WikiPathways_09.11.2015	Metastatic brain tumor	[-1]	[Group12, Group6, Group8]	1	7.142857	0.162587593667113	1.0	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557, Group8=4.8659373939131026E-11}	[MYC]	[CDC42, CDK6, E2F3, MIR101-1, MIR148B, MIR29B1, MIR29B2, MIR34A, MIRLET7A2, MIRLET7B, MIRLET7F2, MYC, PIK3R1, TP53]	FALSE
WP:2261	WikiPathways_09.11.2015	Signaling Pathways in Glioblastoma	[-1]	[Group12]	10	12.048193	5.5102517062181194E-8	4.518406399098858E-6	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[ATM, EGFR, HRAS, KRAS, MAP2K4, MAPK1, MDM2, MET, PDGFRA, PDGFRB]	[AKT1, AKT2, AKT3, ARAF, ATM, BRAF, BRCA1, BRCA2, CBL, CCND1, CCND2, CCNE1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, E2F1, EGFR, EP300, ERBB2, ERBB3, ERRFI1, FGFR1, FGFR2, FOXO1, FOXO3, FOXO4, GAB1, GRB2, HRAS, IGF1R, IRS1, KRAS, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAPK1, MAPK3, MDM2, MDM4, MET, MIR21, MSH6, NF1, NRAS, PDGFRA, PDGFRB, PDPK1, PIK3C2A, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PLCG1, PLCG2, PRKCA, PRKCB, PRKCD, PRKCG, PRKCH, PRKCI, PRKCQ, PRKCZ, PTEN, RAF1, RB1, SPRY2, SRC, TP53, TSC1, TSC2]	TRUE
WP:2289	WikiPathways_09.11.2015	Drug Induction of Bile Acid Pathway	[-1]	[Group10]	1	5.882353	0.1938846352486073	1.0	{Group10=0.0833982410159817}	{Group10=0.5837876871118719}	[NR1I2]	[ABCB1, ABCB11, ABCC2, ABCC3, ABCC4, BAAT, CYP3A4, CYP7A1, NR1H4, NR1I2, NR1I3, SLC10A1, SLC51A, SLC51B, SLCO1B1, SULT2A1, VDR]	FALSE
WP:2290	WikiPathways_09.11.2015	RalA downstream regulated genes	[-1]	[Group12, Group3]	2	16.666666	0.009470906183905552	0.3883071535401276	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, KRAS]	[CDC42, EXOC2, EXOC8, HRAS, KRAS, NRAS, RAC1, RAC2, RAC3, RALA, RALBP1, YBX3]	FALSE
WP:2324	WikiPathways_09.11.2015	AGE/RAGE pathway	[-1]	[Group12]	3	4.5454545	0.049526628245318206	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[EGFR, JAK2, MAPK1]	[AGER, AKT1, ALPL, ATF2, CASP3, CASP8, CASP9, CDC42, CHUK, CYCS, DDOST, DIAPH1, EGFR, EZR, FOXO1, FOXO4, HIF1A, IKBKB, INHBB, INS, INSR, IRAK4, IRS1, JAK2, JUN, LGALS3, MAP2K1, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP13, MMP14, MMP2, MMP7, MMP9, MSN, MSR1, MYD88, NCF1, NFKB1, NFKBIA, NOS2, NOS3, PLA2G4A, PRKCA, PRKCB, PRKCD, PRKCZ, RAC1, RAF1, RELA, RHOA, ROCK1, SHC1, SMAD2, SMAD3, SOD1, SP1, SRC, STAT1, STAT3, STAT5A, STAT5B, TIRAP]	FALSE
WP:2332	WikiPathways_09.11.2015	Interleukin-11 Signaling Pathway	[-1]	[Group12]	4	9.090909	0.002111554235242068	0.10768926599734546	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[HRAS, JAK2, MAPK1, PPP2R4]	[AKT1, ATF1, BCL2, BGLAP, BIRC5, CHUK, CREB1, FES, FYN, GRB2, HRAS, IBSP, ICAM1, IKBKB, IL11, IL11RA, IL6ST, ITGA2, JAK1, JAK2, MAP2K1, MAP2K2, MAPK1, MAPK3, PDPK1, PIAS1, PIAS3, PIK3R1, PIK3R2, PPP2R4, PTPN11, RAF1, RELA, RPS6, RPS6KA1, RPS6KB1, RUNX2, SOCS3, SRC, STAT1, STAT3, TGFB1, TYK2, YES1]	FALSE
WP:2338	WikiPathways_09.11.2015	miRNA Biogenesis	[-1]	[Group9]	1	16.666666	0.07316704195140943	1.0	{Group9=0.09636547000372864}	{Group9=0.4818273500186432}	[DICER1]	[DGCR8, DICER1, DROSHA, RAN, TARBP2, XPO5]	FALSE
WP:2361	WikiPathways_09.11.2015	Gastric Cancer Network 1	[-1]	[Group4]	2	6.8965516	0.050838872965189255	1.0	{Group4=0.050838872965189255}	{Group4=0.40671098372151404}	[CENPF, TOP2A]	[ACTL6A, APC, AURKA, C21orf33, CCNA1, CENPF, CEP192, E2F7, ECT2, ESM1, GATS, H3F3A, HIST4H4, INO80D, KIF15, KIF20B, LIN9, LOC102724023, MCM4, MYBL2, NOTCH1, NUP107, RNF216, RUVBL1, S100P, SMOC2, TOP2A, TPX2, UBE2C]	TRUE
WP:2363	WikiPathways_09.11.2015	Gastric cancer network 2	[-1]	[Group6]	4	12.903226	5.528862356836493E-4	0.03427894661238626	{Group6=1.2876095855903798E-4}	{Group6=0.0015451315027084557}	[ATAD2, EGFR, MYC, TOP2A]	[AHCTF1, ATAD2, BRIX1, CACYBP, CD48, CEBPZ, CHTF18, CHTF8, COL9A1, COL9A3, CTNNB1, DSCC1, EGFR, FAM91A1, FANCI, LBR, LMNB2, MTDH, MYC, OTUD5, PLAC8, RAD17, RFC3, RFC4, RNF144B, S100A6, SNURF, TOP2A, TP53, UBE2C, UBE2T]	FALSE
WP:2369	WikiPathways_09.11.2015	Histone Modifications	[-1]	[Group7]	2	4.0816326	0.1257996684281502	1.0	{Group7=0.17837906818765462}	{Group7=0.5351372045629639}	[EZH2, KMT2E]	[AEBP2, ASH1L, DOT1L, EED, EHMT1, EHMT2, EZH1, EZH2, H3F3A, H3F3B, HIST1H3D, HIST1H3J, HIST1H4C, HIST1H4H, HIST1H4J, HIST2H3A, HIST2H3C, HIST2H3D, HIST4H4, KMT2A, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, NSD1, PRDM2, SET, SETBP1, SETD1A, SETD1B, SETD2, SETD3, SETD4, SETD5, SETD6, SETD7, SETD9, SETDB1, SETDB2, SETMAR, SMYD1, SMYD2, SMYD3, SMYD4, SMYD5, SUV39H1, SUV39H2]	TRUE
WP:2374	WikiPathways_09.11.2015	Oncostatin M Signaling Pathway	[-1]	[Group12, Group3]	5	7.6923075	0.0012344188053099558	0.07406512831859735	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, JAK2, KRAS, MAPK1, MTOR]	[AKT1, CASP3, CASP7, CCL2, CDK2, CDKN1B, CEBPB, CREB1, CYR61, EGR1, FOS, GRB2, HIF1A, HRAS, IL6ST, IRS1, JAK1, JAK2, JAK3, JUNB, JUND, KRAS, LDLR, LIFR, MAP2K1, MAP2K2, MAPK1, MAPK14, MAPK3, MAPK8, MAPK9, MMP1, MMP13, MMP3, MTOR, NFKB1, NFKBIA, OSM, OSMR, PIAS3, PIK3R1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PTK2B, PTPN11, PXN, RAF1, RELA, RICTOR, RPS6, SERPINE1, SHC1, SOCS3, SOS1, SRC, STAT1, STAT3, STAT5B, TIMP3, TP53, TYK2, VEGFA]	FALSE
WP:2377	WikiPathways_09.11.2015	Integrated Pancreatic Cancer Pathway	[-1]	[Group8]	20	10.416667	5.038161712132385E-14	4.18167422106988E-12	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ARF1, ATM, BID, BLM, CCNA2, CHEK1, EGFR, EZH2, FAS, KRAS, MAPK1, MDM2, MYC, PDGFRA, RAD50, RAD51, RRM1, TOP1, TOP2A, WRN]	[ABCB1, ABL1, ACHE, AGPAT2, AKT1, ANXA1, APAF1, APC, APP, AR, ARF1, ATM, BAD, BAX, BBC3, BCL2, BDNF, BID, BLM, BRCA1, BRCA2, BRF1, BUB1B, CAB39, CAMK2A, CAMP, CAPN1, CASP10, CASP12, CASP3, CASP7, CASP8, CASP9, CCNA2, CCND1, CCNE1, CD82, CDC25C, CDK2, CDK4, CDKN1A, CDKN1B, CDKN2B, CHEK1, CHEK2, CHUK, CREB1, CREBBP, CRK, CST3, CTNNB1, DAG1, DAXX, DCC, DFFA, DFFB, E2F1, E2F4, EGF, EGFR, EGR1, EIF2AK2, EP300, ERBB2, ESR1, ESR2, EZH2, FADD, FAS, FASLG, FGF1, FGF2, FGFR1, FKBP1A, FKBP1B, FKBP3, FST, FTL, GADD45A, GPRC5A, GRB2, GSK3A, GTF2A2, HDAC8, HNF4A, HPGDS, HSP90AB1, IAPP, IGF1, IGFBP3, IL11, IL1R1, IL3, INHBA, JUN, JUNB, JUND, KRAS, LEFTY1, LIG1, LTBP1, MAP2K1, MAP3K4, MAP3K5, MAPK1, MAPK14, MAPK3, MAPK4, MAPK7, MAPK8, MAPK9, MAPT, MDM2, MIR21, MNAT1, MRE11A, MST1, MYC, MYT1, NCK1, NFKB1, NFKBIA, NME1, NODAL, NOXA1, NT5C1A, NTF3, NTRK1, PAK1, PCNA, PDGFA, PDGFRA, PDK1, PIAS1, PIK3CA, PITX2, PLA2G4A, PLK1, PLN, PML, POLA1, POLR1A, PPP1R13L, PRKAA2, PRKCA, PTEN, PTGS2, PTTG1, RAC1, RAD50, RAD51, RAD52, RAF1, RAP1A, RAPGEF3, RARA, RARB, RB1CC1, RBL1, RHEB, RRM1, RXRA, SERPINB10, SHH, SIRT1, SMAD2, SMAD4, SMAD6, SMO, SOS1, SP1, SRC, STAT1, STAT5A, STK11, STMN1, TBP, TFF1, TGFB1, TGFBR1, THBS1, TNF, TNFRSF1A, TOP1, TOP2A, TP53, TP53BP2, TRAF2, TYMS, VEGFA, WRN, WT1]	TRUE
WP:2446	WikiPathways_09.11.2015	Retinoblastoma (RB) in Cancer	[-1]	[Group8]	7	7.9545455	1.0032426853467054E-4	0.006922374528892268	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[CCNA2, CCNE2, CHEK1, MDM2, MYC, RRM1, TOP2A]	[ABL1, ANLN, BARD1, CCDC6, CCNA2, CCNB1, CCNB2, CCND1, CCND3, CCNE1, CCNE2, CDC25A, CDC25B, CDC45, CDC7, CDK1, CDK2, CDK4, CDK6, CDKN1A, CDKN1B, CDT1, CHEK1, DCK, DHFR, DNMT1, E2F1, E2F2, E2F3, FAF1, FANCG, H2AFZ, HDAC1, HLTF, HMGB1, HMGB2, KIF4A, MAPK13, MCM3, MCM4, MCM6, MCM7, MDM2, MIR21, MSH6, MYC, NPAT, ORC1, PCNA, PLK4, POLA1, POLD3, POLE, POLE2, PRIM1, PRKDC, PRMT2, RABIF, RAF1, RB1, RBBP4, RBBP7, RBP1, RFC3, RFC4, RFC5, RPA1, RPA2, RPA3, RRM1, RRM2, SAP30, SIN3A, SKP2, SMARCA2, SMC1A, SMC2, SMC3, STMN1, SUV39H1, TFDP1, TFDP2, TOP2A, TP53, TTK, TYMS, WEE1, ZNF655]	FALSE
WP:2447	WikiPathways_09.11.2015	Amyotrophic lateral sclerosis (ALS)	[-1]	[Group1, Group3]	2	5.263158	0.08197457864743607	1.0	{Group1=3.207445269990176E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group3=0.001046860092881383}	[BCL2L1, BID]	[ALS2, APAF1, BAD, BAX, BCL2, BCL2L1, BID, CASP1, CASP12, CASP3, CASP9, CAT, CCS, CST3, DAXX, DERL1, GPX1, GRIA1, MAP2K2, MAP2K6, MAP3K5, MAPK14, NEFH, NEFL, NEFM, NOS1, PPP3CA, PPP3CB, PPP3CC, PRPH, RAB5A, RAC1, SLC1A2, SOD1, TNF, TNFRSF1A, TOMM40, TP53]	FALSE
WP:2453	WikiPathways_09.11.2015	TCA Cycle and PDHc	[-1]	[Group15]	1	6.25	0.1835823018636746	1.0	{Group15=0.2718277548262036}	{Group15=0.2718277548262036}	[CS]	[ACLY, ACO1, CS, DLAT, DLD, DLST, FH, IDH1, IDH3A, MDH1, OGDH, PC, PCK1, PDHA1, SDHA, SUCLG2]	TRUE
WP:2516	WikiPathways_09.11.2015	ATM Signaling Pathway	[-1]	[Group8]	7	17.948717	3.9314718675239634E-7	3.0665480566686914E-5	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, BID, CHEK1, MDM2, RAD50, RAD51, RIPK1]	[ABL1, AP3B2, ATF2, ATM, BID, BRCA1, CASP2, CCNB1, CDC25A, CDC25C, CDK1, CDK2, CDKN1A, CHEK1, CHEK2, CRADD, CREB1, FANCD2, GADD45A, H2AFX, IKBKG, JUN, MAPK9, MDC1, MDM2, MDM4, MRE11A, NBN, NFKBIA, PIDD1, RAD50, RAD51, RAD9A, RIPK1, SMC1A, TLK1, TP53, TP53BP1, TP73]	FALSE
WP:2526	WikiPathways_09.11.2015	PDGF Pathway	[-1]	[Group1, Group12, Group3]	4	10.256411	0.0013407374606838373	0.07776277271966256	{Group1=3.207445269990176E-5, Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group1=4.4904233779862466E-4, Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[HRAS, MAP2K4, MAPK1, PDGFRB]	[ARFIP2, CDC42, CHUK, COX2, ELK1, FOS, GRB2, HRAS, JAK1, JUN, MAP2K1, MAP2K4, MAP3K1, MAPK1, MAPK3, MAPK8, NFKBIA, PAK1, PDGFA, PDGFB, PDGFRB, PIK3R1, PLA2G4A, PLCG1, PTPN11, RAC1, RAF1, RASA1, RHOA, SHC1, SOS1, SRC, SRF, STAT1, STAT3, TIAM1, VAV1, VAV2, WASL]	FALSE
WP:2533	WikiPathways_09.11.2015	Glycerophospholipid Biosynthetic Pathway	[-1]	[Group5]	1	4.7619047	0.23383049362054006	0.9353219744821603	{Group5=0.23383049362054006}	{Group5=0.46766098724108013}	[PI4K2A]	[AGPS, CDIPT, CDS2, CEPT1, CHKB, CHPT1, CRLS1, GK, GNPAT, GPD1, LPIN1, LPIN2, MOGAT3, PCYT2, PEMT, PGS1, PI4K2A, PIP5K1A, PLA2G2A, PTDSS1, PTPMT1]	TRUE
WP:2586	WikiPathways_09.11.2015	Aryl Hydrocarbon Receptor	[-1]	[Group12, Group6]	6	13.043478	1.952173163105951E-5	0.0014250864090673441	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557}	[EGFR, HRAS, KRAS, MAPK1, MYC, RET]	[AHR, AHRR, AIP, ARNT, CCL1, CD36, CDC37, CDK2, CDKN1A, CDKN1B, CYP1A1, CYP1A2, CYP1B1, E2F1, EGFR, EP300, ESR1, FGF21, GCLC, HPGDS, HRAS, HSP90AA1, KLF6, KRAS, LPL, MAP2K1, MAPK1, MYC, NCOA7, NCOR2, NF1, NFE2L2, NFKB1, NQO1, NRAS, NRIP1, PLAGL1, PSRC1, PTGS2, RAF1, RB1, RELA, RET, SRC, TNF, VEGFA]	TRUE
WP:2637	WikiPathways_09.11.2015	Structural Pathway of Interleukin 1 (IL-1)	[-1]	[Group12, Group3]	2	4.255319	0.11745634330005812	1.0	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[MAP2K4, MAPK1]	[ATF2, CHUK, EIF4E, ELK1, FOS, IKBKB, IL1A, IL1R1, IL1RAP, IRAK1, IRAK2, IRAK4, IRF7, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K7, MAP3K8, MAPK1, MAPK10, MAPK11, MAPK14, MAPK3, MAPK8, MAPK9, MAPKAPK2, MBP, MKNK1, MKNK2, MYD88, NFKB1, NFKBIA, NFKBIB, RELA, RPS6KA5, SAFB, TAB1, TAB2, TAB3, TANK, TOLLIP, TRAF6]	FALSE
WP:2643	WikiPathways_09.11.2015	Nanoparticle-mediated activation of receptor signaling	[-1]	[Group12, Group3]	4	14.285714	3.7006361998768604E-4	0.024054135299199593	{Group12=1.2190730591512093E-5, Group3=8.052769945241409E-5}	{Group12=1.828609588726814E-4, Group3=0.001046860092881383}	[EGFR, HRAS, KRAS, MAPK1]	[AKT3, AREG, COL1A1, EGFR, FN1, GRB2, HRAS, ITGA1, ITGB1, KRAS, MAP2K1, MAP2K2, MAPK1, MAPK10, MAPK11, MAPK12, MAPK13, MAPK14, MAPK8, MAPK9, NRAS, PIK3CD, PTK2, PXN, RAF1, SOS1, SRC, TLN1]	FALSE
WP:2795	WikiPathways_09.11.2015	Cardiac Hypertrophic Response	[-1]	[Group12, Group2]	3	5.5555553	0.02982366586757806	1.0	{Group12=1.2190730591512093E-5, Group2=0.025816580286709155}	{Group12=1.828609588726814E-4, Group2=0.2323492225803824}	[MAP2K4, MAPK1, MTOR]	[AKT1, AKT2, CALM1, CAMK2D, CDK7, CDK9, CHUK, EGF, FGF2, FGFR2, GSK3B, GUCA1A, HDAC4, HDAC5, HDAC7, HDAC9, IGF1, IKBKB, IKBKE, IKBKG, MAP2K1, MAP2K2, MAP2K3, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K1, MAP3K14, MAP3K7, MAP4K1, MAPK1, MAPK14, MAPK3, MAPK7, MAPK8, MEF2A, MTOR, NFATC2, NFKB1, NPPA, NRG1, PDPK1, PLA2G2A, PPP3CA, PRKCA, PRKD1, PRKG1, RAC1, RAF1, TGFB1, TGFBR1, TNF, TNFRSF1A]	FALSE
WP:2804	WikiPathways_09.11.2015	Hair Follicle Development: Induction (Part 1 of 3)	[-1]	[Group12, Group6, Group8]	2	4.7619047	0.0972882751797125	1.0	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557, Group8=4.8659373939131026E-11}	[EGFR, MYC]	[BMP4, BMPR1A, CDH3, CHUK, CTGF, CTNNB1, DKK4, DVL1, EDA, EDAR, EGF, EGFR, FGF20, FGF7, FGFR1, FGFR2, FOXI3, FST, FZD1, GJB6, GSK3B, IKBKB, INHBA, IVL, KRT10, LEF1, LRP5, LRP6, MSX2, MYC, NFKB1, NFKBIB, NOG, PTCH1, SHH, SMO, SP5, TCF3, TP63, VCAN, WNT10A, WNT10B]	FALSE
WP:2805	WikiPathways_09.11.2015	RNA interference	[-1]	[Group9]	1	20.0	0.06134914679257509	1.0	{Group9=0.09636547000372864}	{Group9=0.4818273500186432}	[DICER1]	[DGCR8, DICER1, DROSHA, ERI1, XPO5]	FALSE
WP:2828	WikiPathways_09.11.2015	Bladder Cancer	[-1]	[Group12, Group6]	5	16.129032	3.522931096859083E-5	0.0025012810787699486	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557}	[EGFR, HRAS, MAPK1, MDM2, MYC]	[BRAF, CCND1, CDH1, CDK4, CDKN1A, CDKN2A, CXCL8, DAPK1, DAPK2, DAPK3, E2F1, EGF, EGFR, ERBB2, FGFR3, HRAS, MAP2K1, MAP2K2, MAPK1, MDM2, MMP1, MYC, PIK3R1, PIK3R2, RASSF1, RB1, RPS6KA5, THBS1, TP53, TYMP, VEGFA]	FALSE
WP:2868	WikiPathways_09.11.2015	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	[-1]	[Group12, Group6]	2	40.0	0.0015187371317466544	0.08353054224606599	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557}	[EGFR, MAPK1]	[EGFR, JAK1, MAPK1, MAPK3, STAT3]	FALSE
WP:2870	WikiPathways_09.11.2015	Extracellular vesicle-mediated signaling in recipient cells	[-1]	[Group12]	5	16.666666	2.983372803354104E-5	0.0021480284184149548	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[EGFR, HRAS, KRAS, MET, MTOR]	[AKT1, APC, AXIN1, CTNNB1, DKK4, EGFR, ERBB2, HGF, HRAS, KRAS, MET, MFGE8, MTOR, NRAS, PIK3R5, PROM1, RAF1, SMAD2, SMAD3, SMAD4, TGFA, TGFB1, TGFB2, TGFB3, TGFBR1, TGFBR2, TGFBR3, TSPAN8, WNT3A, WNT5A]	FALSE
WP:2875	WikiPathways_09.11.2015	Constitutive Androstane Receptor Pathway	[-1]	[Group10]	2	6.25	0.06064657065399543	1.0	{Group10=0.0833982410159817}	{Group10=0.5837876871118719}	[CYP2C9, PPP2R4]	[ABCB1, ABCC2, ABCC3, ALAS1, CYP2A6, CYP2B6, CYP2C19, CYP2C9, CYP3A4, CYP3A5, CYP4A11, DNAJC7, EHHADH, FOXO1, GSTA2, HSP90AA1, NCOA1, NCOA2, NCOA6, NR1I3, PPARGC1A, PPP2R4, RXRA, SMC1A, SP1, SULT1A1, SULT2A1, UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9]	FALSE
WP:2916	WikiPathways_09.11.2015	Interactome of polycomb repressive complex 2 (PRC2) 	[-1]	[Group7]	1	6.25	0.1835823018636746	1.0	{Group7=0.17837906818765462}	{Group7=0.5351372045629639}	[EZH2]	[AEBP2, BCLAF1, EED, ELL, EZH1, EZH2, JARID2, MORC3, MTF2, RBBP4, RBBP7, SETX, STK38, SUZ12, THRAP3, TRIM35]	FALSE
WP:2942	WikiPathways_09.11.2015	DDX1 as a regulatory component of the Drosha microprocessor	[-1]	[Group8]	2	28.571428	0.0031379621323933686	0.15376014448727507	{Group8=3.041210871195689E-12}	{Group8=4.8659373939131026E-11}	[ATM, RAD50]	[ATM, DDX1, DGCR8, DROSHA, MRE11A, NBN, RAD50]	FALSE
WP:2943	WikiPathways_09.11.2015	Hypoxia-mediated EMT and Stemness	[-1]	[Group9]	1	50.0	0.024999011380813105	0.8999644097092718	{Group9=0.09636547000372864}	{Group9=0.4818273500186432}	[DICER1]	[DICER1, ZEB1]	TRUE
WP:2946	WikiPathways_09.11.2015	Imatinib Resistance in Chronic Myeloid Leukemia	[-1]	[Group11]	4	8.163265	0.003145033852008659	0.15096162489641562	{Group11=0.0034640410527188486}	{Group11=0.038104451579907335}	[CSF1R, MYC, PDGFRA, PDGFRB]	[ABCB1, ABCG2, ABL1, ANXA2R, BBX, BCL11A, BCR, CASZ1, CCND3, CDK6, CDKN1B, CPEB4, CSF1R, EPO, FLT1, FOXO3, GAB1, GAB2, GADD45A, HMGB2, IGF2BP1, KIT, LYL1, LYN, MAP2K6, MAVS, MYC, NOL4L, NOP2, NSD1, PDGFRA, PDGFRB, PEX14, PIM1, PIM2, PRKACA, PTP4A2, PVT1, RAB36, RPS6KA1, SKP2, SLC4A10, SLC4A7, SLC50A1, SLC7A3, SPRED1, SPRED2, TRIM28, ZC3HAV1]	TRUE
WP:3301	WikiPathways_09.11.2015	MFAP5-mediated ovarian cancer cell motility and invasiveness	[-1]	[Group12]	1	8.333333	0.14106206710632815	1.0	{Group12=1.2190730591512093E-5}	{Group12=1.828609588726814E-4}	[MAPK1]	[CREB5, ITGAV, ITGB3, ITPR3, JUN, MAPK1, MFAP5, PLCG1, PRKCQ, PTK2, RYR3, TNNC1]	FALSE
WP:3303	WikiPathways_09.11.2015	Rac1/Pak1/p38/MMP-2 pathway	[-1]	[Group12, Group6, Group8]	6	9.090909	1.557772141730214E-4	0.010437073349592433	{Group12=1.2190730591512093E-5, Group6=1.2876095855903798E-4, Group8=3.041210871195689E-12}	{Group12=1.828609588726814E-4, Group6=0.0015451315027084557, Group8=4.8659373939131026E-11}	[EGFR, HRAS, KRAS, MAPK1, MYC, RAD51]	[AKT1, ANGPT1, ANGPT2, ANGPT4, ANGPTL1, BAD, BAX, BIRC5, CASP7, CASP9, CHUK, CRK, CTNNB1, DOK2, EGFR, EIF4EBP1, ERBB2, FN1, FOXO1, GRB14, GRB2, GRB7, HRAS, IKBKB, ITGB1, KRAS, MAPK1, MAPK11, MAPK12, MAPK13, MAPK14, MAPK3, MAPK8, MAPK9, MSH2, MYC, NCK1, NFKB1, NFKBIA, NOS1, NOS2, NRAS, PAK1, PIK3CA, PIK3R1, PTK2, PTPN11, PXN, RAC1, RAD51, RASA1, RELA, RS1, SOS1, SRC, STAT3, STAT5A, STAT5B, STMN1, TEK, TIE1, TNIP1, TNIP2, TNIP3, TP53, YAP1]	FALSE
